v3.25.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Loss from operations $ (7,977,171) $ (13,197,451)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 676,200 796,831
Amortization of intangible assets 565 565
Inducement expense 4,464,427
Cost of commitment shares issued 74,999
Change in fair value contingent consideration (150,000)
Loss on equity method investment 492,130 552,183
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 8,572 63,358
Accrued expenses 100,296 199,709
Accrued expenses, related party (47,942)
Accounts payable and other current liabilities 405,077 146,805
Accounts payable, related party (48,272) 24,210
Net cash used in operating activities (6,492,603) (6,922,306)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Cash receipt from contingent consideration 150,000
Net cash provided by investing activities 150,000
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from sale of common stock 3,658,552 4,021,485
Proceeds from warrant exercise, net of expenses 4,814,743 3,824,264
Net cash provided by financing activities 8,473,295 7,845,749
NET INCREASE IN CASH AND CASH EQUIVALENTS 2,130,692 923,443
CASH AND CASH EQUIVALENTS-BEGINNING OF YEAR 3,750,525 2,827,082
CASH AND CASH EQUIVALENTS-END OF YEAR 5,881,217 3,750,525
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Issuance of common stock to settle bonus accrual $ 36,050